Income Statement - ArriVent BioPharma, Inc. (AVBP)
$(Billion, Million)| Sep-25 | Sep-24 | Sep-23 | Sep-22 | Sep-21 | |
|---|---|---|---|---|---|
| Total revenue | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total operating expenses | 0.18 | 0.09 | 0.07 | 0.04 | 0.01 |
| Operating income | -0.18 | -0.09 | -0.07 | -0.04 | -0.01 |
| Non-operating income (net) | 0.01 | 0.01 | 0.01 | 0.00 | -0.04 |
| Income before tax | -0.17 | -0.08 | -0.07 | -0.04 | -0.05 |
| Income tax expense | -0.08 | -0.04 | -0.01 | ||
| Net income | -0.17 | -0.08 | -0.07 | -0.04 | -0.05 |
Show Quarterly Income Statement
Income Statement - ArriVent BioPharma, Inc. (AVBP)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Total operating expenses | 0.05 | 0.04 | 0.04 | 0.03 | 0.07 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Operating income | -0.05 | -0.04 | -0.04 | -0.03 | -0.07 | -0.02 | -0.02 | -0.03 | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Non-operating income (net) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income before tax | -0.04 | -0.04 | -0.03 | -0.03 | -0.06 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Income tax expense | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | ||||||||||||
| Net income | -0.04 | -0.04 | -0.03 | -0.03 | -0.06 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |